100 Participants Needed

Cognitive Processing Therapy + Memory Support for PTSD

JC
Overseen ByJoseph Carpenter, PhD MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Boston University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it requires that any psychiatric medication dose be stable for the past four weeks before participating.

What data supports the effectiveness of the treatment Cognitive Processing Therapy + Memory Support for PTSD?

Cognitive Processing Therapy (CPT) is a well-researched treatment that has been shown to effectively reduce PTSD symptoms in various groups, including combat veterans and sexual assault survivors. Studies have demonstrated significant improvements in PTSD and depression symptoms, with benefits maintained over time. Additionally, CPT has been adapted to address co-occurring issues like alcohol dependence, showing promise in improving both PTSD and related problems.12345

Is Cognitive Processing Therapy (CPT) safe for humans?

Cognitive Processing Therapy (CPT) is widely regarded as a safe treatment for post-traumatic stress disorder (PTSD) and has been effectively used in various settings, including among military veterans and within the Department of Veterans Affairs healthcare system.24678

How is Cognitive Processing Therapy (CPT) unique in treating PTSD?

Cognitive Processing Therapy (CPT) is unique because it focuses on changing the way individuals process traumatic events by addressing their thoughts and beliefs, which can lead to behavioral changes and symptom improvement. It is particularly effective for PTSD and can be adapted for group or individual settings, and even modified to address co-occurring issues like heavy alcohol use.12349

What is the purpose of this trial?

The efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (MS) intervention into Cognitive Processing Therapy (CPT), an empirically supported and widely disseminated treatment for PTSD. MS was designed to integrate techniques aimed at facilitating encoding, consolidation, and retrieval of new learning into existing treatments, and has been shown to improve outcomes when integrated into cognitive therapy for depression. A pilot randomized controlled trial (n=52) comparing CPT with Memory Support (CPT+MS) to CPT-alone will be conducted. Study participants will be adults diagnosed with PTSD.The primary aim of the trial will be to determine if CPT+MS will lead to greater memory and learning of therapy content relative to CPT-alone, and to establish the acceptability and feasibility of integrating MS into CPT. Secondary aims include a preliminary examination of treatment efficacy, as indicated by the magnitude of changes in PTSD symptoms between conditions, and target validation, as indicated by associations between memory and learning of therapy content and treatment response. Exploratory analyses will examine several indicators of baseline memory-related cognitive functioning as predictors of memory and learning of therapy content, providing preliminary data to inform future research on personalized application of MS. Results of the trial will advance scientific knowledge about methods for optimizing memory and learning as a mechanism for improving PTSD treatment outcomes.

Research Team

JC

Joseph Carpenter, PhD MA

Principal Investigator

VA Boston Healthcare System, BUSM Psychiatry Dept.

Eligibility Criteria

Adults with PTSD can join this study. They must have a stable dose of psychiatric meds for the last month if they're taking any, and veterans are specifically welcomed. People with unstable bipolar disorder, psychosis, severe substance abuse, or past severe brain injury cannot participate. Also excluded are those with high verbal memory skills or significant cognitive impairment.

Inclusion Criteria

Veteran status
My psychiatric medication dose has been the same for the last month.
I have been diagnosed with PTSD by a professional.

Exclusion Criteria

Current DSM-5 diagnoses of unstable bipolar disorder, past or present psychosis, or organic mental disorder
Significant cognitive impairment as indicated by a score <10th percentile on the Montreal Cognitive Assessment
History of moderate or severe traumatic brain injury (TBI) based on the Ohio State University TBI Identification Method and Veterans Administration/ Department of Defense (VA/DOD) guidelines
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Cognitive Processing Therapy (CPT) with or without Memory Support (MS) for PTSD

12 weeks
Weekly therapy sessions

Mid-treatment

Assessment of memory of therapy content and client satisfaction

6 weeks
1 assessment visit

Post-treatment

Evaluation of changes in PTSD symptoms, depression, and cognitive functioning

12 weeks
1 assessment visit

Follow-up

Participants are monitored for long-term changes in PTSD symptoms and memory of therapy content

6 months
1 follow-up visit

Treatment Details

Interventions

  • Cognitive Processing Therapy (CPT)
  • Memory Support (MS)
Trial Overview The trial is testing whether adding Memory Support (MS) to Cognitive Processing Therapy (CPT) helps people remember therapy content better than CPT alone. It's a small-scale test involving 52 adults to see if it's feasible and acceptable to combine these treatments for PTSD.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Processing Therapy + Memory Support (CPT + MS)Experimental Treatment2 Interventions
CPT + MS will involve the same treatment strategies as CPT while incorporating deliberate and frequent use of memory and learning support strategies. MS strategies are designed to enhance the memory of specific treatment points, defined as any insight, skill or strategy determined to be important for the patient to remember and/or implement. MS is not designed to enhance memory functioning generally, but rather improve the encoding, consolidation and retrieval of specific components of therapeutic learning.
Group II: Cognitive Processing Therapy (CPT)Active Control1 Intervention
CPT is a manualized, trauma-focused therapy for PTSD. Treatment consists of psychoeducation on the cognitive model of PTSD, identification of trauma-related stuck points (i.e. dysfunctional beliefs), and cognitive challenging techniques to help participants identify more realistic and adaptive ways of viewing their trauma, themselves, and the world.

Cognitive Processing Therapy (CPT) is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Cognitive Processing Therapy for:
  • Posttraumatic Stress Disorder (PTSD)
🇪🇺
Approved in European Union as Cognitive Processing Therapy for:
  • Posttraumatic Stress Disorder (PTSD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston University

Lead Sponsor

Trials
494
Recruited
9,998,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

VA Boston Healthcare System

Collaborator

Trials
73
Recruited
971,000+

Findings from Research

A 12-week course of modified Cognitive Processing Therapy (CPT-C) effectively improved PTSD symptoms and reduced alcohol dependence in a combat veteran, showing promise for treating co-occurring conditions.
The veteran maintained significant improvements in both PTSD and alcohol-related issues 12 weeks after completing the treatment, suggesting the long-term efficacy of this enhanced therapy.
Case report on the use of cognitive processing therapy-cognitive, enhanced to address heavy alcohol use.McCarthy, E., Petrakis, I.[2022]
In a study of 268 active-duty servicemembers, individual cognitive processing therapy (CPT) was found to be more effective than group CPT in reducing PTSD severity, with significant improvements noted immediately after treatment.
Both individual and group formats of CPT led to reductions in depression and suicidal ideation, but about 50% of participants still experienced PTSD symptoms after treatment, highlighting the need for improved or new therapeutic options in this population.
Effect of Group vs Individual Cognitive Processing Therapy in Active-Duty Military Seeking Treatment for Posttraumatic Stress Disorder: A Randomized Clinical Trial.Resick, PA., Wachen, JS., Dondanville, KA., et al.[2022]
Cognitive Processing Therapy (CPT) significantly improved PTSD and depression symptoms in 19 sexual assault survivors after 12 weekly group sessions, with benefits maintained for 6 months post-treatment.
In contrast, a comparison group of 20 individuals who waited for therapy showed no improvement, highlighting the efficacy of CPT in treating PTSD symptoms.
Cognitive processing therapy for sexual assault victims.Resick, PA., Schnicke, MK.[2022]

References

Case report on the use of cognitive processing therapy-cognitive, enhanced to address heavy alcohol use. [2022]
Effect of Group vs Individual Cognitive Processing Therapy in Active-Duty Military Seeking Treatment for Posttraumatic Stress Disorder: A Randomized Clinical Trial. [2022]
Cognitive processing therapy for sexual assault victims. [2022]
Dissemination and experience with cognitive processing therapy. [2022]
Cognitive processing therapy for posttraumatic stress disorder in a residential treatment setting. [2019]
Examination of PTSD symptom networks over the course of cognitive processing therapy. [2023]
Study protocol for a randomised controlled trial of cognitive processing therapy for post-traumatic stress disorder among Japanese patients: the Safety, Power, Intimacy, Esteem, Trust (SPINET) study. [2019]
Using the multiphase optimization strategy to adapt cognitive processing therapy (CPT MOST): study protocol for a randomized controlled factorial experiment. [2023]
Neurocognitive Predictors of Treatment Outcomes in Cognitive Processing Therapy for Post-traumatic Stress Disorder: Study Protocol. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security